T-cell subsets in lymph nodes identify a subgroup of follicular lymphoma patients with favorable outcome

Leuk Lymphoma. 2017 Apr;58(4):842-850. doi: 10.1080/10428194.2016.1217525. Epub 2016 Aug 11.

Abstract

We have analyzed in lymph nodes at diagnosis of 75 patients with follicular lymphoma (FL) the relationship between different T-cell subpopulations, assessed by immunohistochemistry (IHC) and flow cytometry (FC), with the outcome. CD4+ cells were the most abundant T-cells in tumor tissue sections, whilst CD57+ cells were the less frequent. In addition to nonambulatory performance status, advanced stage and FLIPI, low CD4+CD57+/CD4+ ratio (p = .041), and low CD4+/CD8+ ratio (p = .008) predicted poor overall survival (OS). Multivariate analysis showed that CD4+CD57+/CD4+ ratio was the most important variable for OS. In conclusion, T-cell subpopulations, including CD4+CD57+/CD4+ ratio analyzed by FC, could identify FL patients with favorable outcome.

Keywords: CD4+CD57+ cells; Follicular lymphoma; prognosis.

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biomarkers
  • Female
  • Humans
  • Immunophenotyping
  • Lymph Nodes / pathology*
  • Lymphoma, Follicular / diagnosis*
  • Lymphoma, Follicular / drug therapy
  • Lymphoma, Follicular / metabolism
  • Lymphoma, Follicular / mortality*
  • Male
  • Middle Aged
  • Neoplasm Grading
  • Neoplasm Staging
  • Prognosis
  • Survival Analysis
  • T-Lymphocyte Subsets / metabolism*

Substances

  • Biomarkers